Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2018

Mar 5, 2018

29828_dirs_2018-03-05_29985ed8-7f22-4033-ab75-3c417d714fca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-03-01

Reporting Person: MOORE NICHOLAS G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-01 Common Stock M 178 Acquired 12233 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-01 Phantom Stock $0 M 178 Disposed Common Stock (178) Direct

Footnotes

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2: An aggregate of 178.180639 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.180639 was paid out in cash in connection with the conversion into shares of common stock.

F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.